Bausch + Lomb Recalls Intraocular Lense Products After Reports of Inflammatory Reactions

MT Newswires Live

Mar 27, 2025

Bausch + Lomb (BLCO) said Thursday it is voluntarily recalling the intraocular lenses on its enVista platform after reports of complications.

The company said it received an increased number of reports of toxic anterior segment syndrome related to its enVista Aspire, enVista Envy, and certain enVista monofocal intraocular lenses. The syndrome is an inflammatory reaction inside the eye typically caused by the introduction of toxic substances into the eye.

The company said that the cause of the incidents "could not immediately be explained."

"These reports represent an extremely small percentage of implanted lenses, with a positive prognosis for everyone involved," said Brent Saunders, chairman and CEO of Bausch + Lomb. "We look forward to identifying a root cause and bringing the enVista platform back to market."

Bausch + Lomb shares were down by more than 4% in premarket trading.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2522957377"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2522957377\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2522957377?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-27 20:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2522957377","market":"nz","top_or_hot":-1,"title":"Bausch + Lomb Recalls Intraocular Lense Products After Reports of Inflammatory Reactions","media":"MT Newswires Live","content":"<html><body><p> Bausch + Lomb (BLCO) said Thursday it is voluntarily recalling the intraocular lenses on its enVista platform after reports of complications.</p><p>The company said it received an increased number of reports of toxic anterior segment syndrome related to its enVista Aspire, enVista Envy, and certain enVista monofocal intraocular lenses. The syndrome is an inflammatory reaction inside the eye typically caused by the introduction of toxic substances into the eye.</p><p>The company said that the cause of the incidents \"could not immediately be explained.\"</p><p>\"These reports represent an extremely small percentage of implanted lenses, with a positive prognosis for everyone involved,\" said Brent Saunders, chairman and CEO of Bausch + Lomb. \"We look forward to identifying a root cause and bringing the enVista platform back to market.\"</p><p>Bausch + Lomb shares were down by more than 4% in premarket trading.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bausch + Lomb Recalls Intraocular Lense Products After Reports of Inflammatory Reactions</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBausch + Lomb Recalls Intraocular Lense Products After Reports of Inflammatory Reactions\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-03-27 20:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Bausch + Lomb (BLCO) said Thursday it is voluntarily recalling the intraocular lenses on its enVista platform after reports of complications.</p><p>The company said it received an increased number of reports of toxic anterior segment syndrome related to its enVista Aspire, enVista Envy, and certain enVista monofocal intraocular lenses. The syndrome is an inflammatory reaction inside the eye typically caused by the introduction of toxic substances into the eye.</p><p>The company said that the cause of the incidents \"could not immediately be explained.\"</p><p>\"These reports represent an extremely small percentage of implanted lenses, with a positive prognosis for everyone involved,\" said Brent Saunders, chairman and CEO of Bausch + Lomb. \"We look forward to identifying a root cause and bringing the enVista platform back to market.\"</p><p>Bausch + Lomb shares were down by more than 4% in premarket trading.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BLCO","symbol_name":"博士伦","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2522957377","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2522957377","pubTimestamp":1743077893,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Bausch + Lomb  said Thursday it is voluntarily recalling the intraocular lenses on its enVista platform after reports of complications.The company said it received an increased number of reports of toxic anterior segment syndrome related to its enVista Aspire, enVista Envy, and certain enVista monofocal intraocular lenses. The syndrome is an inflammatory reaction inside the eye typically caused by the introduction of toxic substances into the eye.The company said that the cause of the incidents \"could not immediately be explained.\"\"These reports represent an extremely small percentage of implanted lenses, with a positive prognosis for everyone involved,\" said Brent Saunders, chairman and CEO of Bausch + Lomb. \"We look forward to identifying a root cause and bringing the enVista platform back to market.\"Bausch + Lomb shares were down by more than 4% in premarket trading.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BLCO":"博士伦","BK4198":"医疗保健用品"},"translate_title":"博士伦收到炎症反应报告后召回人工晶状体产品","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BLCO":0.9},"content_text":"Bausch + Lomb (BLCO) said Thursday it is voluntarily recalling the intraocular lenses on its enVista platform after reports of complications.The company said it received an increased number of reports of toxic anterior segment syndrome related to its enVista Aspire, enVista Envy, and certain enVista monofocal intraocular lenses. The syndrome is an inflammatory reaction inside the eye typically caused by the introduction of toxic substances into the eye.The company said that the cause of the incidents \"could not immediately be explained.\"\"These reports represent an extremely small percentage of implanted lenses, with a positive prognosis for everyone involved,\" said Brent Saunders, chairman and CEO of Bausch + Lomb. \"We look forward to identifying a root cause and bringing the enVista platform back to market.\"Bausch + Lomb shares were down by more than 4% in premarket trading.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}